In this randomised , double-blind , placebo-controlled , parallel-group phase @ trial , we recruited patients ( aged @-@ years ) from @ sites ( hospitals and independent clinical research organisations ) in the Netherlands and Denmark with fasting LDL cholesterol levels between @ mmol/L and @ mmol/L , HDL cholesterol levels between @ and @ mmol/L and triglyceride levels below @ mmol/L after washout of lipid-lowering treatments .